Search
01/03/2026
Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).
14/01/2026
Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort
Torres, G, Gracia-Lavedan, E, González, J, Henríquez-Beltrán, M, Targa, ADS, Royo, M, Bermúdez-López, M, Castro-Boqué, E, Valdivielso, JM, Pamplona, R, Mauricio, D, Lecube, A, Barbé, F, De Batlle, J, Miquel, E, Ortega, M, Portero-Otín, M, Jové, M, Hernández, M, Rius, F, Franch-Nadal, J, Castelblanco, E, Godoy, P, Martinez-Alonso, M, Simó, R, Hernández, C, Fernández, E. Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-33414-8. PMID:41535697. IF:3.900(Q1/2D).
06/01/2026
Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort
León-Mengíbar, J, Malagón, MM, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro, E, Fernández, E, Caixàs, A, Hernández, M, Lopez-Cano, C, Gordon, A, Guzman-Ruiz, R, Cusi, K, Lecube, A. Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort. Frontiers in Endocrinology. 2026; 16DOI:10.3389/fendo.2025.1651689. PMID:41567808. IF:4.600(Q1/3D).
01/01/2026
In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used
Xie, XL, Liu, JM, López, A, Garcia-Patterson, A, Adelantado, JM, López, E, Corcoy, R. In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used. ACTA DIABETOLOGICA. 2026; 63(1)DOI:10.1007/s00592-025-02587-z. PMID:41055719. IF:2.900(Q3/6D).
01/01/2026
Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data
Navarro-González, JF, de Isla, LP, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Almanza, MR, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, Blanco-Carrasco, AJ, Torres, JFM. Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data. Kidney Diseases. 2026; 12(1)DOI:10.1159/000547604. PMID:41510180. IF:3.100(Q1/3D).
01/01/2026
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study
Ritzel, R, Davies, MJ, Hao, LC, Ji, LN, Lintu, MK, Mabunay, A, Mauricio, D, Bailey, T. Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study. Diabetes Therapy. 2026; 17(1)DOI:10.1007/s13300-025-01798-5. PMID:41269514. IF:2.600(Q3/6D).